Who are the PLWH who might refuse to participate in HIV cure-related clinical trials with treatment interruption? - Archive ouverte HAL Access content directly
Journal Articles AIDS Year : 2020

Who are the PLWH who might refuse to participate in HIV cure-related clinical trials with treatment interruption?

(1, 2) , (2, 1) , (2, 1) , (3) , (2) , (4, 1, 5) , (6) , (7) , (8) , (9, 2) , (2)
1
2
3
4
5
6
7
8
9
Marie Préau

Abstract

Achieving a HIV cure has become a research priority. As any improvement of knowledge, which could help scientists design new HIV cure-related clinical trials (HCRCT) depends on the risks potential participants are willing to accept, it is important to understand who will agree or refuse to participate and in which proportions. By providing insights into factors associated with reluctance toward HCRCT participation, our results may help clinicians in patient recruitment.
Fichier principal
Vignette du fichier
Protiere C_.pdf (412.28 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-02547988 , version 1 (18-05-2021)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

Cite

Christel Protière, Marion Fiorentino, Abdourahmane Sow, Marie Préau, Marion Mora, et al.. Who are the PLWH who might refuse to participate in HIV cure-related clinical trials with treatment interruption?. AIDS, 2020, pp.1. ⟨10.1097/QAD.0000000000002530⟩. ⟨hal-02547988⟩
65 View
110 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More